Tumor invasion unit in gastric cancer revealed by QDs-based in situ molecular imaging and multispectral analysis

Biomaterials

Volumn 35, Issue 13, 2014, Pages 4125-4132

  Hu, Wen Qing ^a   Fang, Min ^b   Zhao, Hao Liang ^c   Yan, Shu Guang ^d   Yuan, Jing Ping ^b   Peng, Chun Wei ^b   Yang, Gui Fang ^b   Li, Yan ^b   Li, Jian Ding ^a  

^a SHANXI MEDICAL UNIVERSITY   (China)

^b ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^c Shanxi Cancer Hospital   (China)

^d CHANGZHI MEDICAL COLLEGE   (China)

Author keywords

Gastric cancer; Molecular imaging; Multispectral analysis; Quantum dots; Tumor invasion unit; Tumor microenvironment of metastasis

Indexed keywords

CLINICAL OUTCOME; GASTRIC CANCERS; IMAGING TECHNOLOGY; MULTI-SPECTRAL ANALYSIS; OVERALL SURVIVAL; PREDICTIVE POWER; TUMOR INVASION; TUMOR MICROENVIRONMENT;

DISEASES; HISTOLOGY; IMAGING TECHNIQUES; MOLECULAR IMAGING; PATHOLOGY; SEMICONDUCTOR QUANTUM DOTS;

TUMORS;

QUANTUM DOT;

ADULT; ALGORITHM; ARTICLE; CANCER CELL; CANCER PROGNOSIS; CANCER SURVIVAL; CANCER TISSUE; CELL INTERACTION; COMPUTER AIDED DESIGN; FEMALE; HUMAN; HUMAN TISSUE; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MOLECULAR IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; STOMACH CANCER; TUMOR INVASION; TUMOR MICROENVIRONMENT; AGED; DIAGNOSTIC IMAGING; IN VITRO STUDY; MIDDLE AGED; PROCEDURES; STOMACH NEOPLASMS;

AGED; DIAGNOSTIC IMAGING; FEMALE; HUMANS; IN VITRO TECHNIQUES; MALE; MIDDLE AGED; MOLECULAR IMAGING; QUANTUM DOTS; STOMACH NEOPLASMS;

EID: 84896720185     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.01.059     Document Type: Article

References (30)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
2. Chen W., Zheng R., Zhang S., Zhao P., Li G., Wu L., et al. The incidences and mortalities of major cancers in China, 2009. Chin J Cancer 2013, 32:106-112.
3. Hanahan D., Weinberg Robert A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
4. Gerlinger M., Rowan A.J., Horswell S., Larkin J., Endesfelder D., Gronroos E., et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. NEngl J Med 2012, 366:883-892.
5. Rosner M., Hengstschlager M. Targeting epigenetic readers in cancer. NEngl J Med 2012, 367:1764-1765.
6. Page-McCaw A., Ewald A.J., Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 2007, 8:221-233.
7. Yasui W., Oue N., Aung P.P., Matsumura S., Shutoh M., Nakayama H. Molecular-pathological prognostic factors of gastric cancer: a review. Gastric Cancer 2005, 8:86-94.
8. Peng C.W., Tian Q., Yang G.F., Fang M., Zhang Z.L., Peng J., et al. Quantum-dots based simultaneous detection of multiple biomarkers of tumor stromal features to predict clinical outcomes in gastric cancer. Biomaterials 2012, 33:5742-5752.
9. Robinson B.D., Sica G.L., Liu Y.F., Rohan T.E., Gertler F.B., Condeelis J.S., et al. Tumor microenvironment of metastasis in human breast carcinoma: a potential prognostic marker linked to hematogenous dissemination. Clin Cancer Res 2009, 15:2433-2441.
10. Wyckoff J.B., Wang Y., Lin E.Y., Li J.F., Goswami S., Stanley E.R., et al. Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res 2007, 67:2649-2656.
11. Fang M., Yuan J.P., Peng C.W., Pang D.W., Li Y. Quantum dots-based in situ molecular imaging of dynamic changes of collagen IV during cancer invasion. Biomaterials 2013, 34:8708-8717.
12. Peng C.W., Wang L.W., Zeng W.J., Yang X.J., Li Y. Evaluation of the staging systems for gastric cancer. JSurg Oncol 2013, 108:93-105.
13. Peng C.W., Wang L.W., Fang M., Yang G.F., Li Y., Pang D.W. Combined features based on MT1-MMP expression, CD11b+ immunocytes density and LNR predict clinical outcomes of gastric cancer. JTransl Med 2013, 11:153.
14. Peng C.W., Liu X.L., Liu X., Li Y. Co-evolution of cancer microenvironment reveals distinctive patterns of gastric cancer invasion: laboratory evidence and clinical significance. JTransl Med 2010, 8:101.
15. Chen C., Sun S.R., Gong Y.P., Qi C.B., Peng C.W., Yang X.Q., et al. Quantum dots-based molecular classification of breast cancer by quantitative spectroanalysis of hormone receptors and HER2. Biomaterials 2011, 32:7592-7599.
16. Taylor C.R., Levenson R.M. Quantification of immunohistochemistry-issues concerning methods, utility and semiquantitative assessment II. Histopathology 2006, 49:411-424.
17. Fantin A., Vieira J.M., Gestri G., Denti L., Schwarz Q., Prykhozhij S., et al. Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction. Blood 2010, 116:829-840.
18. Stockmann C., Doedens A., Weidemann A., Zhang N., Takeda N., Greenberg J.I., et al. Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis. Nature 2008, 456:814-818.
19. Wyckoff J., Wang W., Lin E.Y., Wang Y., Pixley F., Stanley E.R., et al. Aparacrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res 2004, 64:7022-7029.
20. Psaila B., Lyden D. The metastatic niche: adapting the foreign soil. Nat Rev Cancer 2009, 9:285-293.
21. Kaplan R.N., Riba R.D., Zacharoulis S., Bramley A.H., Vincent L., Costa C., et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005, 438:820-827.
22. Comen E., Norton L., Massague J. Clinical implications of cancer self-seeding. Nat Rev Clin Oncol 2011, 8:369-377.
23. Kim M.Y., Oskarsson T., Acharyya S., Nguyen D.X., Zhang X.H., Norton L., et al. Tumor self-seeding by circulating cancer cells. Cell 2009, 139:1315-1326.
24. Liu Q., Zhang A., Xu W., Dong J. Anew view of the roles of blood flow dynamics and Kupffer cell in intra-hepatic metastasis of hepatocellular carcinoma. Med Hypotheses 2011, 77:87-90.
25. Mantovani A., Locati M. Tumor-associated macrophages as a paradigm of macrophage plasticity, diversity, and polarization: lessons and open questions. Arterioscler Thromb Vasc Biol 2013, 33:1478-1483.
26. Kerbel R.S. Tumor angiogenesis. NEngl J Med 2008, 358:2039-2049.
27. Rolny C., Mazzone M., Tugues S., Laoui D., Johansson I., Coulon C., et al. HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF. Cancer Cell 2011, 19:31-44.
28. Sethi N., Kang Y. Unravelling the complexity of metastasis-molecular understanding and targeted therapies. Nat Rev Cancer 2011, 11:735-748.
29. Kairdolf B.A., Smith A.M., Stokes T.H., Wang M.D., Young A.N., Nie S. Semiconductor quantum dots for bioimaging and biodiagnostic applications. Annu Rev Anal Chem (Palo Alto Calif) 2013, 6:143-162.
30. Chen C., Peng J., Sun S.R., Peng C.W., Li Y., Pang D.W. Tapping the potential of quantum dots for personalized oncology: current status and future perspectives. Nanomedicine (Lond) 2012, 7:411-428.